Pub. Date : 2019 Jul 2
PMID : 31240976
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Background The angiotensin-receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin-converting enzyme inhibitor enalapril in terms of reducing cardiovascular mortality in the PARADIGM-HF (Prospective Comparison of ARNI with angiotensin-converting enzyme inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure) study. | Valsartan | angiotensin I converting enzyme | Homo sapiens |